- ROUNDTABLE: Pharmacy’s future in sync with technology
- Mylan launches generic version of Prandin
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- FDA approves liquid form of Merck HIV drug Isentress for infants, small children
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
PITTSBURGH — The Food and Drug Administration has approved a blood pressure medication made by Mylan.
The drug maker announced Friday the approval of valsartan and hydrochlorothiazide tablets in the 80-mg/12.5-mg, 160-mg/12.5-mg, 160-mg/25-mg, 320-mg/12.5-mg and 320-mg/25-mg strengths.
The drug, a generic version of Novartis' Diovan HCT, is used to treat high blood pressure, or hypertension, in patients who can't control their blood pressure with one drug or who are starting therapy and need multiple drugs.
Various versions of the drug had sales of $1.6 billion during the 12-month period ended in June, according to IMS Health.